GI Innovation-LaNova Signs MOU for GI-102 + ADC Cancer Therapy
22 Jan 2025 //
PR NEWSWIRE
GI Innovation To Evaluate GI-102 With KEYTRUDA In Resistant Cancers
26 Aug 2024 //
BUSINESSWIRE
GI Innovation Recruits CEO Byung-Geon Rhee
04 Mar 2022 //
BUSINESSWIRE